9 months ago
TNYA
AnalystsJoseph PantginisJoseph Pantginis's Stock Forecasts
AnalystsJoseph Pantginis
Analyst Ranking
Top 5%
#252 out of 5124 analysts
Average Return
+3.86%
Win Rate
41%388 out of 948
Risk vs Reward
Poor
Good
Joseph Pantginis's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Celldex Therapeutics IncCLDX | +1,183.78% | $1.85 | $23.75 | 2020-03-26 - 2021-03-26 | Buy |
Cidara Therapeutics IncCDTX | +936.98% | $21.31 | $220.98 | 2025-06-17 - 2025-12-03 | Buy |
Alpine Immune Sciences IncALPN | +694.86% | $8.17 | $64.94 | 2023-05-11 - 2024-05-10 | Buy |
Biomea Fusion IncBMEA | +644.47% | $4.79 | $35.66 | 2022-06-01 - 2023-06-01 | Buy |
Capricor Therapeutics IncCAPR | +501.06% | $2.84 | $17.07 | 2023-10-03 - 2024-10-03 | Buy |
Joseph Pantginis Analyst Color
Get additional color on Joseph Pantginis's coverage of popular stocks
a year ago
BLRX
a year ago
CAPR
2 years ago
VKTX
Joseph Pantginis's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Capricor Therapeutics IncCAPR | 26 | Buy | $60.00 | +100.27% | Maintains | a day ago |
Fractyl Health IncGUTS | 3 | Buy | $8.00 | +316.67% | Reiterates | 2 days ago |
Shattuck Labs IncSTTK | 16 | Buy | $6.00 | +130.77% | Upgrades | 3 days ago |
Travere Therapeutics IncTVTX | 6 | Buy | $47.00 | +34.86% | Reiterates | 6 days ago |
Biomx IncPHGE | 17 | Buy | $26.00 | +476.50% | Reiterates | 8 days ago |
Lineage Cell Therapeutics IncLCTX | 13 | Buy | $9.00 | +435.71% | Maintains | 10 days ago |
Pds Biotechnology CorpPDSB | 31 | Buy | $15.00 | +1,662.63% | Maintains | 21 days ago |
Ligand Pharmaceuticals IncLGND | 20 | Buy | $231.00 | +19.67% | Maintains | a month ago |
Iovance Biotherapeutics IncIOVA | 27 | Buy | $9.00 | +307.24% | Maintains | a month ago |
Kura Oncology IncKURA | 23 | Buy | $40.00 | +234.17% | Reiterates | a month ago |
Newamsterdam Pharma Co NvNAMS | 1 | Buy | $52.00 | +46.40% | Assumes | a month ago |
Rigel Pharmaceuticals IncRIGL | 23 | Buy | $57.00 | +20.74% | Reiterates | 2 months ago |
Cytokinetics IncCYTK | 46 | Buy | $120.00 | +85.59% | Reiterates | 2 months ago |
Viking Therapeutics IncVKTX | 34 | Buy | $102.00 | +188.05% | Reiterates | 2 months ago |
Biocardia IncBCDA | 16 | Buy | $25.00 | +1,660.56% | Reiterates | 2 months ago |
Esperion Therapeutics IncESPR | 29 | Buy | $16.00 | +323.28% | Reiterates | 3 months ago |
Astria Therapeutics IncATXS | 23 | Buy | $20.00 | +52.79% | Maintains | 3 months ago |
Krystal Biotech IncKRYS | 32 | Buy | $240.00 | +10.37% | Reiterates | 3 months ago |
Lexicon Pharmaceuticals IncLXRX | 23 | Buy | $4.00 | +185.71% | Reiterates | 3 months ago |
Tenaya Therapeutics IncTNYA | 18 | Buy | $5.00 | +275.94% | Reiterates | 3 months ago |
Neuphoria Therapeutics IncNEUP | 8 | Buy | $21.00 | +401.19% | Reiterates | 3 months ago |
Lisata Therapeutics IncLSTA | 18 | Buy | $15.00 | +679.22% | Reiterates | 3 months ago |
Fortress Biotech IncFBIO | 3 | Buy | $17.00 | +531.97% | Maintains | 3 months ago |
Celldex Therapeutics IncCLDX | 35 | Buy | $42.00 | +51.02% | Maintains | 3 months ago |
Sensei Biotherapeutics IncSNSE | 1 | Buy | $30.00 | +244.83% | Maintains | 4 months ago |
Nuvectis Pharma IncNVCT | 9 | Buy | $10.00 | +56.74% | Maintains | 4 months ago |
Edgewise Therapeutics IncEWTX | 1 | Buy | $42.00 | +80.10% | Initiates Coverage On | 5 months ago |
Phio Pharmaceuticals CorpPHIO | 2 | Buy | $14.00 | +985.27% | Reiterates | 5 months ago |
Cidara Therapeutics IncCDTX | 2 | Buy | $53.00 | -76.02% | Maintains | 5 months ago |
Actinium Pharmaceuticals IncATNM | 30 | Buy | $4.00 | +175.86% | Reiterates | 5 months ago |
Moleculin Biotech IncMBRX | 2 | Buy | $100.00 | +1,217.52% | Reiterates | 6 months ago |
Galectin Therapeutics IncGALT | 1 | Buy | $6.00 | +4.17% | Assumes | 6 months ago |
Biolinerx LtdBLRX | 13 | Buy | $26.00 | +707.45% | Reiterates | 6 months ago |
Gri Bio IncGRI | 3 | Buy | $10.00 | +405.05% | Reiterates | 6 months ago |
Atyr Pharma IncATYR | 23 | Buy | $35.00 | +4,439.56% | Reiterates | 6 months ago |
Xoma Royalty CorpXOMA | 24 | Buy | $104.00 | +235.48% | Reiterates | 6 months ago |
Armata Pharmaceuticals IncARMP | 15 | Buy | $9.00 | +50.25% | Maintains | 7 months ago |
Curis IncCRIS | 1 | Buy | $17.00 | +1,260.00% | Assumes | 7 months ago |
Cadrenal Therapeutics IncCVKD | 5 | Buy | $32.00 | +261.17% | Reiterates | 7 months ago |
Calcimedica IncCALC | 12 | Buy | $16.00 | +241.15% | Reiterates | 7 months ago |
Fibrogen IncFGEN | 3 | Buy | $250.00 | +2,978.82% | Reiterates | 7 months ago |
Iterum Therapeutics PLCITRM | 1 | Buy | $9.00 | +2,058.27% | Assumes | 7 months ago |
Biomea Fusion IncBMEA | 29 | Buy | $18.00 | +1,614.29% | Maintains | 7 months ago |
Vyne Therapeutics IncVYNE | 20 | Buy | $4.50 | +1,100.00% | Maintains | 7 months ago |
Compass Therapeutics IncCMPX | 18 | Buy | $24.00 | +354.55% | Reiterates | 7 months ago |
Tempest Therapeutics IncTPST | 19 | Hold | $16.00 | +389.30% | Downgrades | 8 months ago |
Clene IncCLNN | 29 | Buy | $31.00 | +329.36% | Reiterates | 8 months ago |
Kairos Pharma LtdKAPA | 1 | Buy | $12.00 | +1,320.12% | Initiates Coverage On | 8 months ago |
Aptose Biosciences IncAPTOF | 15 | Buy | $6.00 | +250.88% | Maintains | 8 months ago |
Pharming Group NvPHAR | 17 | Buy | $37.00 | +134.03% | Reiterates | 8 months ago |
Omniab IncOABI | 7 | Buy | $11.00 | +485.11% | Reiterates | 9 months ago |
Checkpoint Therapeutics IncCKPT | 17 | Hold | $4.10 | -3.76% | Downgrades | 9 months ago |
Palatin Technologies IncPTN | 27 | Buy | $7.00 | -59.06% | Maintains | 10 months ago |
Aprea Therapeutics IncAPRE | 14 | Buy | $20.00 | +1,841.75% | Reiterates | a year ago |
Adlai Nortye LtdANL | 3 | Buy | $9.00 | N/A | Reiterates | a year ago |
Genenta Science SpaGNTA | 4 | Buy | $25.00 | N/A | Reiterates | a year ago |
Biora Therapeutics IncBIOR | 9 | Buy | $150.00 | N/A | Reiterates | a year ago |
Mustang Bio IncMBIO | 6 | Buy | $100.00 | N/A | Reiterates | 2 years ago |
Panbela Therapeutics IncPBLA | 8 | Buy | $5.00 | N/A | Maintains | 2 years ago |
Alpine Immune Sciences IncALPN | 7 | Buy | $50.00 | N/A | Maintains | 2 years ago |
Traws Pharma IncTRAW | 9 | Buy | $11.00 | N/A | Reiterates | 2 years ago |
Biophytis SaBPTSY | 5 | Buy | $600.00 | N/A | Reiterates | 2 years ago |
Decibel Therapeutics IncDBTX | 5 | Buy | $23.00 | N/A | Reiterates | 2 years ago |
Atreca IncBCEL | 5 | Buy | $25.00 | N/A | Reiterates | 2 years ago |
Aravive IncARAV | 9 | Buy | $12.00 | N/A | Reiterates | 2 years ago |
Xenetic Biosciences IncXBIO | 3 | Buy | $40.00 | N/A | Reiterates | 3 years ago |
IMV IncIMVIQ | 1 | Buy | $65.00 | N/A | Reiterates | 3 years ago |
Applied Genetic Technologies CorpAGTC | 3 | Hold | N/A | N/A | Downgrades | 3 years ago |
Akouos IncAKUS | 2 | Hold | N/A | N/A | Downgrades | 3 years ago |
Humanigen IncHGENQ | 3 | Hold | N/A | N/A | Downgrades | 3 years ago |
Genocea Biosciences IncGNCAQ | 2 | Hold | N/A | N/A | Downgrades | 4 years ago |
Sierra Oncology IncSRRA | 1 | Hold | $55.00 | N/A | Downgrades | 4 years ago |
Sio Gene Therapies IncSIOX | 3 | Buy | $7.00 | N/A | Maintains | 4 years ago |
Beyondspring IncBYSI | 4 | Hold | N/A | N/A | Downgrades | 4 years ago |
Essa Pharma IncEPIX | 3 | Buy | $32.00 | N/A | Maintains | 5 years ago |
Strata Skin Sciences IncSSKN | 1 | Buy | $30.00 | N/A | Upgrades | 5 years ago |
Principia Biopharma IncPRNB | 4 | Hold | $100.00 | N/A | Downgrades | 5 years ago |
Avid Bioservices IncCDMO | 2 | Buy | $9.00 | N/A | Reiterates | 6 years ago |
Immune Design CorpIMDZ | 1 | Buy | $7.75 | N/A | Maintains | 7 years ago |
Tg Therapeutics IncTGTX | 2 | Buy | $33.00 | N/A | Assumes | 8 years ago |
Soligenix IncSNGX | 1 | Buy | $2,640.00 | N/A | Initiates Coverage On | 8 years ago |
Palvella Therapeutics IncPVLA | 1 | Strong Buy | $720.00 | N/A | Initiates Coverage On | 9 years ago |
Verastem IncVSTM | 1 | Buy | $78.00 | N/A | Reiterates | 9 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.